Search research articles
Contact Us
Filters
Showing results (161-170 of 519) with videos related to
Page
of 52
Sort By:
International Journal of Cancer
|
February 11, 2012
Borrelia and subsequent risk of solid tumors and hematologic malignancies in Sweden
Cindy M Chang, Ola Landgren, Jill Koshiol, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 16, 2012
Free light chains and the risk of AIDS-defining opportunistic infections in HIV-infected individuals
Meredith S Shiels, Ola Landgren, Rene Costello, et al.
JAMA Oncology
|
November 19, 2020
Assessment of Discordance Among Smoldering Multiple Myeloma Risk Models
Elizabeth Hill, Alexander Dew, Candis Morrison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2011
Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes
Sigurdur Y Kristinsson, Magnus Björkholm, Malin Hultcrantz, et al.
Haematologica
|
December 5, 2014
Smoldering multiple myeloma: special considerations surrounding treatment on versus off clinical trials
Elisabet E Manasanch, Neha Korde, Sham Mailankody, et al.
Leukemia & Lymphoma
|
October 9, 2012
Serum free light chains as predictors of lymphomagenesis in patients with autosomal dominant hyper-immunoglobulin E syndrome (Job's syndrome)
Elisabet E Manasanch, Alexandra F Freeman, Stefania Pittaluga, et al.
International Journal of Cancer
|
January 6, 2006
Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study
Ola Landgren, Martha S Linet, Mary L McMaster, et al.
JAMA Oncology
|
November 27, 2018
Remission and Progression-Free Survival in Patients With Newly Diagnosed Multiple Myeloma Treated With Carfilzomib, Lenalidomide, and Dexamethasone: Five-Year Follow-up of a Phase 2 Clinical Trial
Dickran Kazandjian, Neha Korde, Sham Mailankody, et al.
Haematologica
|
December 6, 2006
Respiratory tract infections in the pathway to multiple myeloma: a population-based study in Scandinavia
Ola Landgren, Joshua S Rapkin, Lene Mellemkjaer, et al.
Gastroenterology
|
October 28, 2008
Increased risk for non-Hodgkin lymphoma in individuals with celiac disease and a potential familial association
Ying Gao, Sigurdur Y Kristinsson, Lynn R Goldin, et al.
Page
of 52
Search research articles
Search
Showing results (161-170 of 519) with videos related to
Sort By:
Page
of 52
International Journal of Cancer
|
February 11, 2012
Borrelia and subsequent risk of solid tumors and hematologic malignancies in Sweden
Cindy M Chang, Ola Landgren, Jill Koshiol, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 16, 2012
Free light chains and the risk of AIDS-defining opportunistic infections in HIV-infected individuals
Meredith S Shiels, Ola Landgren, Rene Costello, et al.
JAMA Oncology
|
November 19, 2020
Assessment of Discordance Among Smoldering Multiple Myeloma Risk Models
Elizabeth Hill, Alexander Dew, Candis Morrison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2011
Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes
Sigurdur Y Kristinsson, Magnus Björkholm, Malin Hultcrantz, et al.
Haematologica
|
December 5, 2014
Smoldering multiple myeloma: special considerations surrounding treatment on versus off clinical trials
Elisabet E Manasanch, Neha Korde, Sham Mailankody, et al.
Leukemia & Lymphoma
|
October 9, 2012
Serum free light chains as predictors of lymphomagenesis in patients with autosomal dominant hyper-immunoglobulin E syndrome (Job's syndrome)
Elisabet E Manasanch, Alexandra F Freeman, Stefania Pittaluga, et al.
International Journal of Cancer
|
January 6, 2006
Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study
Ola Landgren, Martha S Linet, Mary L McMaster, et al.
JAMA Oncology
|
November 27, 2018
Remission and Progression-Free Survival in Patients With Newly Diagnosed Multiple Myeloma Treated With Carfilzomib, Lenalidomide, and Dexamethasone: Five-Year Follow-up of a Phase 2 Clinical Trial
Dickran Kazandjian, Neha Korde, Sham Mailankody, et al.
Haematologica
|
December 6, 2006
Respiratory tract infections in the pathway to multiple myeloma: a population-based study in Scandinavia
Ola Landgren, Joshua S Rapkin, Lene Mellemkjaer, et al.
Gastroenterology
|
October 28, 2008
Increased risk for non-Hodgkin lymphoma in individuals with celiac disease and a potential familial association
Ying Gao, Sigurdur Y Kristinsson, Lynn R Goldin, et al.
Page
of 52